Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma Multiforme (WHO Grade IV)”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Testing effectiveness (Phase 2)Ended earlyNCT01011231
What this trial is testing

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Who this might be right for
Glioblastoma
University of California, San Francisco 1
Early research (Phase 1)Active Not RecruitingNCT04606316
What this trial is testing

Surgical Nivolumab And Ipilimumab For Recurrent GBM

Who this might be right for
GlioblastomaGBMGlioblastoma Multiforme+1 more
Patrick Wen, MD 63
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Testing effectiveness (Phase 2)Ended earlyNCT04915404
What this trial is testing

Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Who this might be right for
Recurrent Glioblastoma Multiforme
WPD Pharmaceuticals Sp. z o.o. 5
Early research (Phase 1)Study completedNCT02709226
What this trial is testing

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT02343406
What this trial is testing

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Who this might be right for
Glioblastoma
AbbVie 266
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195139
What this trial is testing

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Who this might be right for
Glioblastoma Multiforme
University of Sydney 103
Testing effectiveness (Phase 2)Study completedNCT03778294
What this trial is testing

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Who this might be right for
GlioblastomaMalignant Glioma
Mayo Clinic 43
Very early researchLooking for participantsNCT04135807
What this trial is testing

Implantable Microdevice In Primary Brain Tumors

Who this might be right for
Grade II GliomaGrade III GliomaGrade IV Glioma+5 more
Oliver Jonas 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03919071
What this trial is testing

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic Astrocytoma, Not Otherwise SpecifiedAnaplastic Ganglioglioma+5 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Looking for participantsNCT05565118
What this trial is testing

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

Who this might be right for
High Grade GliomaGlioblastoma
Case Comprehensive Cancer Center 10
Early research (Phase 1)Study completedNCT01240460
What this trial is testing

Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection

Who this might be right for
GlioblastomaAstrocytoma, Grade IV
Sanofi 40
Testing effectiveness (Phase 2)Study completedNCT00104091
What this trial is testing

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 56
Early research (Phase 1)Study completedNCT02903069
What this trial is testing

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Who this might be right for
GlioblastomaMalignant Glioma
Celgene 66
Early research (Phase 1)Study completedNCT01172964
What this trial is testing

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more
City of Hope Medical Center 15
Very early researchActive Not RecruitingNCT05182905
What this trial is testing

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Who this might be right for
GlioblastomaGliomaGlioblastoma Multiforme+1 more
Nader Sanai 97
Not applicableStudy completedNCT07673679
What this trial is testing

GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4

Who this might be right for
GliomaGlioma (Diagnosis)Astrocytoma+2 more
Deep Learning Institute of Radiological Sciences 1,372
Early research (Phase 1)Looking for participantsNCT07560865
What this trial is testing

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Who this might be right for
AstrocytomaGlioblastomaProgressive Disease
Masonic Cancer Center, University of Minnesota 9
Early research (Phase 1)Active Not RecruitingNCT06632236
What this trial is testing

5G-EMERALD: Amivantamab in Malignant Brain Tumours

Who this might be right for
Malignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more
Institute of Cancer Research, United Kingdom 12
Next Page